• Non-Catalytic Sub-Selective p38alpha-Specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-Inflammatory Activity, and Methods of Use Thereof

    Published On: March 17th, 2023
    Continue Reading

  • SILCS-RNA: Toward a Structure-Based Drug Design Approach for Targeting RNAs with Small Molecules

    Published On: March 17th, 2023
    Continue Reading

  • Rapid and accurate estimation of protein–ligand relative binding affinities using site-identification by ligand competitive saturation

    Published On: March 17th, 2023
    Continue Reading

  • Functional Group Distributions, Partition Coefficients, and Resistance Factors in Lipid Bilayers Using Site Identification by Ligand Competitive Saturation

    Published On: March 17th, 2023
    Continue Reading

  • Alex MacKerell, PhD, SilcsBio Co-founder & CSO, Co-Leads Study on Use of SILCS Technology to Improve Lung Disease Treatments

    Article in Proceedings of the National Academy of Sciences illustrates use of SILCS mapping technology to improve treatments for asthma and chronic obstructive pulmonary disease December 14, 2022, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced its Co-Founder and Chief Scientific Officer, Alexander [...]

    Published On: December 14th, 2022
    Continue Reading

Connect with us today to learn more about how we can help your team work faster and more efficiently.

    Browse by Categories